These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 33507812)

  • 1. Prostate cancer GTV delineation with biparametric MRI and
    Hearn N; Blazak J; Vivian P; Vignarajah D; Cahill K; Atwell D; Lagopoulos J; Min M
    Br J Radiol; 2021 Mar; 94(1119):20201174. PubMed ID: 33507812
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Draulans C; Pos F; Smeenk RJ; Kerkmeijer L; Vogel WV; Nagarajah J; Janssen M; Mai C; Heijmink S; van der Leest M; Zámecnik P; Oyen R; Isebaert S; Maes F; Joniau S; Kunze-Busch M; De Roover R; Defraene G; van der Heide UA; Goffin K; Haustermans K
    Pract Radiat Oncol; 2021; 11(3):202-211. PubMed ID: 33941347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of gross tumour volume delineation with [68Ga]-PSMA-PET compared to histopathology for high-risk prostate cancer.
    Zarei M; Wallsten E; Grefve J; Söderkvist K; Gunnlaugsson A; Sandgren K; Jonsson J; Keeratijarut Lindberg A; Nilsson E; Bergh A; Zackrisson B; Moreau M; Thellenberg Karlsson C; Olsson LE; Widmark A; Riklund K; Blomqvist L; Berg Loegager V; Axelsson J; Strandberg SN; Nyholm T
    Acta Oncol; 2024 Jun; 63():503-510. PubMed ID: 38912830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manual and semi-automated delineation of locally advanced rectal cancer subvolumes with diffusion-weighted MRI.
    Hearn N; Bugg W; Chan A; Vignarajah D; Cahill K; Atwell D; Lagopoulos J; Min M
    Br J Radiol; 2020 Oct; 93(1114):20200543. PubMed ID: 32877210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI versus ⁶⁸Ga-PSMA PET/CT for gross tumour volume delineation in radiation treatment planning of primary prostate cancer.
    Zamboglou C; Wieser G; Hennies S; Rempel I; Kirste S; Soschynski M; Rischke HC; Fechter T; Jilg CA; Langer M; Meyer PT; Bock M; Grosu AL
    Eur J Nucl Med Mol Imaging; 2016 May; 43(5):889-897. PubMed ID: 26592938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of
    Zamboglou C; Drendel V; Jilg CA; Rischke HC; Beck TI; Schultze-Seemann W; Krauss T; Mix M; Schiller F; Wetterauer U; Werner M; Langer M; Bock M; Meyer PT; Grosu AL
    Theranostics; 2017; 7(1):228-237. PubMed ID: 28042330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraindividual comparison between
    Spohn S; Jaegle C; Fassbender TF; Sprave T; Gkika E; Nicolay NH; Bock M; Ruf J; Benndorf M; Gratzke C; Grosu AL; Zamboglou C
    Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2796-2803. PubMed ID: 32342192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network.
    Kostyszyn D; Fechter T; Bartl N; Grosu AL; Gratzke C; Sigle A; Mix M; Ruf J; Fassbender TF; Kiefer S; Bettermann AS; Nicolay NH; Spohn S; Kramer MU; Bronsert P; Guo H; Qiu X; Wang F; Henkenberens C; Werner RA; Baltas D; Meyer PT; Derlin T; Chen M; Zamboglou C
    J Nucl Med; 2021 Jun; 62(6):823-828. PubMed ID: 33127624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gross tumor volume delineation in primary prostate cancer on
    Zhang YN; Lu ZG; Wang SD; Lu X; Zhu LL; Yang X; Fu LP; Zhao J; Wang HF; Xiang ZL
    Cancer Imaging; 2022 Jul; 22(1):36. PubMed ID: 35869521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic efficiency of hybrid imaging using PSMA ligands, PET/CT, PET/MRI and MRI in identifying malignant prostate lesions.
    Scobioala S; Kittel C; Wolters H; Huss S; Elsayad K; Seifert R; Stegger L; Weckesser M; Haverkamp U; Eich HT; Rahbar K
    Ann Nucl Med; 2021 May; 35(5):628-638. PubMed ID: 33742373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [
    Bettermann AS; Zamboglou C; Kiefer S; Jilg CA; Spohn S; Kranz-Rudolph J; Fassbender TF; Bronsert P; Nicolay NH; Gratzke C; Bock M; Ruf J; Benndorf M; Grosu AL
    Radiother Oncol; 2019 Dec; 141():214-219. PubMed ID: 31431366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability of gross tumour volume delineation: MRI and CT based tumour and lymph node delineation for lung radiotherapy.
    Kumar S; Holloway L; Boxer M; Yap ML; Chlap P; Moses D; Vinod S
    Radiother Oncol; 2022 Feb; 167():292-299. PubMed ID: 34896156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal
    Draulans C; De Roover R; van der Heide UA; Kerkmeijer L; Smeenk RJ; Pos F; Vogel WV; Nagarajah J; Janssen M; Isebaert S; Maes F; Mai C; Oyen R; Joniau S; Kunze-Busch M; Goffin K; Haustermans K
    Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1211-1218. PubMed ID: 33025093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3 Tesla multiparametric MRI for GTV-definition of Dominant Intraprostatic Lesions in patients with Prostate Cancer--an interobserver variability study.
    Rischke HC; Nestle U; Fechter T; Doll C; Volegova-Neher N; Henne K; Scholber J; Knippen S; Kirste S; Grosu AL; Jilg CA
    Radiat Oncol; 2013 Jul; 8():183. PubMed ID: 23875672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal dose escalation for prostate cancer using
    Zamboglou C; Thomann B; Koubar K; Bronsert P; Krauss T; Rischke HC; Sachpazidis I; Drendel V; Salman N; Reichel K; Jilg CA; Werner M; Meyer PT; Bock M; Baltas D; Grosu AL
    Radiat Oncol; 2018 May; 13(1):81. PubMed ID: 29716617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot study comparing dominant intraprostatic lesion volume using Ga-68 prostate-specific membrane antigen PET-computed tomography and multiparametric MRI.
    Sasidharan A; Murthy V; Natarajan A; Agarwal A; Ranagrajan V; Gudi S; Singh S; Popat P
    Nucl Med Commun; 2020 Dec; 41(12):1291-1298. PubMed ID: 32941400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating diffusion-weighted magnetic resonance imaging for target volume delineation in head and neck radiotherapy.
    Cardoso M; Min M; Jameson M; Tang S; Rumley C; Fowler A; Estall V; Pogson E; Holloway L; Forstner D
    J Med Imaging Radiat Oncol; 2019 Jun; 63(3):399-407. PubMed ID: 30816646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathology-validated gross tumor volume delineations of intraprostatic lesions using PSMA-positron emission tomography/multiparametric magnetic resonance imaging.
    Grefve J; Söderkvist K; Gunnlaugsson A; Sandgren K; Jonsson J; Keeratijarut Lindberg A; Nilsson E; Axelsson J; Bergh A; Zackrisson B; Moreau M; Thellenberg Karlsson C; Olsson LE; Widmark A; Riklund K; Blomqvist L; Berg Loegager V; Strandberg SN; Nyholm T
    Phys Imaging Radiat Oncol; 2024 Jul; 31():100633. PubMed ID: 39286772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of [(11)C]choline Positron Emission Tomography With T2- and Diffusion-Weighted Magnetic Resonance Imaging for Delineating Malignant Intraprostatic Lesions.
    Chang JH; Lim Joon D; Davis ID; Lee ST; Hiew CY; Esler S; Gong SJ; Wada M; Clouston D; O'Sullivan R; Goh YP; Bolton D; Scott AM; Khoo V
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):438-45. PubMed ID: 25864171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of
    Walacides D; Meier A; Knöchelmann AC; Meinecke D; Derlin T; Bengel FM; Ross TL; Wester HJ; Derlin K; Kuczyk MA; von Klot CAJ; Christiansen H; Henkenberens C
    Strahlenther Onkol; 2019 May; 195(5):420-429. PubMed ID: 30610354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.